Global Balloon Catheter Market Set for Robust Growth, Expected to Reach US$ 6.4 Billion by 2033

Balloon Catheter Market
Balloon Catheter Market

A new report published today forecasts significant growth in the global balloon catheter market, with an anticipated compound annual growth rate (CAGR) of 4.3% from 2023 to 2033. The market, which was valued at approximately US$ 4.2 billion in 2023, is projected to reach US$ 6.4 billion by the end of 2033.

This growth is primarily driven by continuous innovations and technological advancements in balloon catheter designs, catering especially to complex medical procedures. Industry leaders are at the forefront of developing groundbreaking technologies that enhance the efficiency, safety, and comfort of medical interventions.

Request A Report Sample:

Innovations Steering Market Growth:

One of the standout innovations in this sector is the introduction of the TrakTip™ design. Utilizing a unique laser-bonded technique, this design ensures a seamless and smooth bonding along the catheter shaft, offering exceptional control and maneuverability during procedures.

Another significant advancement is the development of occlusion balloon catheters. These are specially designed to minimize the movement of stone fragments during Percutaneous Nephrolithotomy (PCNL) procedures. By stabilizing stone fragments, these catheters enhance patient safety and improve the efficacy of the treatment.

Highlighting the Mustang Catheter:

A prime example of innovation in this market is the Mustang catheter, developed by a leading industry player. The Mustang catheter is notable for its reduced sheath diameters, enhancing patient comfort and reducing procedure times. It also features superior capabilities in crossing and tracking, forceful dilatation, and is available in longer lengths, which significantly boosts its effectiveness across various medical scenarios.

Market Prospects:

“The balloon catheter market is experiencing a transformation driven by technological innovation,” stated FMI. “With advancements such as the TrakTip™ design and the development of the Mustang catheter, we are not only meeting the current demands of the healthcare industry but are also paving the way for future medical procedures that prioritize patient safety and procedural efficiency.”

This growth and innovation in the balloon catheter market highlight its crucial role in modern medical practices, ensuring that the industry remains at the cutting edge of healthcare advancements.

Beyond these advancements, the market offers a variety of balloon catheter solutions to address diverse clinical needs:

  • Balloon dilatation catheters for radial dilatation of the urinary tract: These catheters are designed to ease strictures and allow for the placement of larger surgical instruments, facilitating minimally invasive procedures.
  • PTA quick exchange balloon dilatation catheters: These catheters cater to the need for accessing and treating lesions in small veins, particularly below the knee, offering a convenient and efficient solution for interventional procedures.

The anticipated growth of the balloon catheter market underscores the increasing demand for minimally invasive procedures and the continuous advancements in medical technology. These advancements are not only driving market expansion but also contributing to improved patient outcomes and minimally invasive treatment options.

Request Methodology Now:

Key Takeaways from the Balloon Catheter Market:

  • From 2023 to 2033, the United Kingdom market is likely to accelerate at a CAGR of 8% and reach a value of US$ 273.4 million in 2033.
  • Germany market is also anticipated to expand at 7% CAGR and reach US$ 244.3 million in 2033.
  • The global balloon catheter market is expected to register 4.3% CAGR between 2023 and 2033.
  • A value of US$ 6.4 billion is estimated for the global balloon catheter market in the year 2033.
  • The global balloon catheter market is poised to reach a valuation of US$ 4.2 billion in 2023.
  • Rising prevalence of peripheral artery disease (PAD) is slated to fuel the need for balloon catheters in Europe.

“As peripheral artery disease is on rise in Europe, balloon catheter adoption is expected to skyrocket in the coming years. Key players are focusing on developing catheters that improve treatment outcomes.”– Says an FMI Analyst.

Competition Landscape in the Balloon Catheter Market:

To set themselves apart from their rivals in the industry and boost sales in the global balloon catheter market, manufacturing companies are concentrating on merger and acquisition strategies.

  • Boston Scientific Inc.,
  • Medtronic,
  • Terumo Corporation,
  • B. Braun Melsungen AG,
  • MicroPort Scientific Corporation,
  • Jotech GmbH,
  • QX Medical LLC,
  • Meril Life Pvt. Ltd.,
  • Hexacath,
  • Abbott Laboratories

Recent Developments:

  • In October 2022, Biosense Webster, Inc., a Johnson & Johnson subsidy of medical technologies, revealed its European debut of a HELIOSTAR balloon catheter, the first radiofrequency balloon ablation catheter. It can be utilised for cardiac ablation when coupled with a suitable cross RF generator and catheter-based heart electrophysiological imaging of the atria.
  • In July 2021, PrevailTM drug coated balloon (DCB) catheters were introduced in Europe under the CE (Conformité Européenne) standard by Medtronic plc, a leading company in medical technology. The Prevail DCB is used in percutaneous coronary intervention (PCI) treatments to treat blocked or restricted blood vessels in people with cardiovascular disease.

Purchase Now to Access:

Key Segments Profiled in the Balloon Catheter Market Survey:

By Product Type:

  • Normal
  • Cutting
  • Scoring
  • Drug Eluting
  • Others

By Raw Material:

  • Polyurethane
  • Nylon
  • Others

By Indication:

  • Coronary Artery Disease
  • Peripheral Vascular Disease

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

About the Author

Ronak Shah

Associate Vice President at Future Market Insights is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers' shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these